MannKind Corp (NASDAQ:MNKD)
| 4.17 Delayed Data As of Dec 03 |  -0.25 / -5.66%Today’s Change | 2.68 Today|||52-Week Range 6.25 | +33.23% Year-to-Date |
Latest MNKD News | Press Releases
No recent news for MannKind Corp.
Today’s Trading
| Previous close | 4.42 |
| Today’s open | 4.39 |
| Day’s range | 4.17 - 4.41 |
| Volume | 110,071 |
| Average volume (3 months) | 2,706,457 |
| Market cap | $1.1B |
Data as of 4:07pm ET, 12/03/2021
Growth & Valuation
| Earnings growth (last year) | +3.09% |
| Earnings growth (this year) | -3.45% |
| Earnings growth (next 5 years) | +30.20% |
| Revenue growth (last year) | +3.34% |
| P/E ratio | NM |
| Price/Sales | 10.69 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RVNCRevance Therapeutics... | -0.19 | -1.28% |
| ---- | ||
| ---- | ||
| MGNXMacroGenics Inc | -0.90 | -5.19% |
Data as of 4:00pm ET, 12/03/2021
Financials
| Next reporting date | March 1, 2022 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $65.1M |
| Annual profit (last year) | -$57.2M |
| Net profit margin | -87.87% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Westlake Village, California |
Forecasts
